Dr. Reddy's Lab launches Deferasirox Tablets for Oral Suspension

06 Dec 2019 Evaluate

Dr. Reddy's Laboratories has launched Deferasirox Tablets for Oral Suspension, a therapeutically equivalent generic version of Exjade (deferasirox) Tablets for Oral Suspension, approved by the US Food and Drug Administration (USFDA).

The Exjade brand had US sales of approximately $113 million MAT for the most recent twelve months ending in September 2019 according to IQVIA Health. Dr. Reddy's Deferasirox Tablets for Oral Suspension, are available in 125 mg, 250 mg, and 500 mg dosage strengths in bottle count sizes of 30.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

6217.15 265.95 (4.47%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.